Clinical Trials Logo

Covid19 clinical trials

View clinical trials related to Covid19.

Filter by:

NCT ID: NCT06349655 Completed - COVID-19 Clinical Trials

The Real-world Clinical Study of Azvudine Tablets in the Treatment of COVID-19

Start date: December 5, 2023
Phase:
Study type: Observational

To establish a real-world clinical cohort and database of Azvudine in the treatment of SARS-CoV-2 infection, and to provide stable and reliable evidence for the clinical efficacy and safety evaluation of azvudine in the treatment of SARS-CoV-2 infection.

NCT ID: NCT06346210 Completed - COVID-19 Clinical Trials

Optimal Timing for Tracheostomy in Invasively Mechanically Ventilated COVID-19 Patients

Start date: April 2, 2024
Phase:
Study type: Observational

Tracheostomy is a medical procedure performed on the front of a persons neck. It is used to create a connection between the persons trachea and a mechanical ventilator instead of using a tube going through the mouth into the trachea, oral intubation. Living with a tracheostomy tube is less stressful compared to oral intubation and facilitate being awake and the start of training on spontaneous ventilation in mechanically ventilated patients. Studies of the timing of tracheostomy are either severely affected by methodological bias of to small to determine an effect. Thus, it is not known what the optimal timing of the tracheostomy is in mechanically ventilated COVID-19 patients.

NCT ID: NCT06330883 Completed - COVID-19 Clinical Trials

Determining the Prevalence of Frailty and Evaluating Its Relationship With Mortality.

Start date: January 1, 2022
Phase:
Study type: Observational [Patient Registry]

Covid-19 patients admitted to the intensive care unit of Selcuk University Hospital were included in the study. Clinical frailty score was given during admission to the intensive care unit. Demographic data, laboratory data, radiological imaging and vital signs of the patients were recorded. Treatment and patient positions were recorded during the intensive care follow-up of the patients. Mortality status of the patients 6 months after admission to the ICU was recorded.

NCT ID: NCT06330389 Completed - Clinical trials for SARS-CoV-2 Infection

Burn Injuries During COVID-19 Pandemic and Its Influence on Length of Stay

Start date: April 1, 2020
Phase:
Study type: Observational

Burn injuries were thought to be difficult to treat during the new corona virus epidemic. Our goal is to determine the risk factors that influence length of hospital stay (LOS) of burn injured patients during COVID -19 pandemic.

NCT ID: NCT06328595 Completed - COVID-19 Clinical Trials

Muscular and Joint Symptoms in COVID-19 Patients: Insights From Syria

Start date: April 22, 2022
Phase:
Study type: Observational [Patient Registry]

Observation study, shows the relation between musckeloskeletal symptoms with during and post Covid-19 infection, by asking participants questions about there age,job,which vaccination covid participants took, residual area, social status, number of time of covid-19 infection, number of joint affected and duration of joint pain and asking if there any malaise or fatigue

NCT ID: NCT06321367 Completed - Covid19 Clinical Trials

Model to Predict Coinfection in Elderly Patients With COVID-19

Start date: December 20, 2022
Phase:
Study type: Observational [Patient Registry]

The goal of this observational study is to learn about the clinical characteristics and construction of a predictive model in elderly COVID-19 patients. The main question it aims to answer is the main clinical characteristics and risk factors of elderly COVID-19 patients. Participants will not be asked to do any other intervening measure.

NCT ID: NCT06318208 Completed - Clinical trials for SARS-CoV-2 Infection

Pulmonary Function in Non-hospitalized Adults and Children After Mild COVID-19

Start date: April 20, 2021
Phase:
Study type: Observational

The study investigates whether patients with mild SARS-CoV-2 infection, who stayed at home during their infection and weren't hospitalized, have any persisting sequelae in pulmonary function. Therefore, 110 patients, aged 6-60 years, were recruited by telephone 4-12 weeks after laboratory-confirmed positive PCR and invited for a lung function testing. Every patient with abnormalities in pulmonary function was invited to a follow-up 3 months after the first appointment to assess changes in lung function values. Patients with a pre-existing lung disease and smokers within the last five years were excluded beforehand. Additionally to lung function testing we did a throat swab at each appointment to analyse via Multiplex PCR whether the patients had any other respiratory infection at the time of the pulmonary function testing.

NCT ID: NCT06311448 Completed - Clinical trials for COVID-19 Acute Respiratory Distress Syndrome

Personalized Targeted Immunomodulation in COVID-19 ARDS

COMODULATE
Start date: March 2, 2020
Phase:
Study type: Observational

Rationale: In COVID19 single-targeted immunomodulation, mostly via an IL-6 receptor blocker, was used by a one-size fits all non-targeted approach. In future pandemics the same might occur. However, for individual patients, this might not yield optimal treatment. Objectives: This project aims to identify a way to individualize and target immunomodulation, using COVID19 as a testcase for the future. - Identify immunological pathways which are associated with outcome in C-ARDS. - Test whether an individualized biomarker-based approach has an effect on outcome and costs when using single-target immunomodulation in C-ARDS(Tocilizumab, Anakinra, etc.). - Explore whether other immunological pathways were present in patients with C-ARDS which could have been intervened with medication which is already available and has been described in ARDS or similar diseases. Study type: Retrospective observational multicenter study in the Netherlands. Study population: Adult patients (≥ 18 years) hospitalized and admitted to the ICU with COVID-19 and acute respiratory distress syndrome (ARDS) (i.e., receiving invasive mechanical ventilation) will be included. Intervention (if applicable): Not applicable (retrospective study design). Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Given the retrospective nature of the study, no burden, risks or benefits for the patient are associated with participation. The target population of this study is specific to hospitalized patients with COVID-19.

NCT ID: NCT06309212 Completed - Clinical trials for The Prevalance of HMPV After COVID-19 Pandemic

Assessing the Impact of COVID-19 on HMPV Incidence and Severity Among Adults

Start date: December 15, 2023
Phase:
Study type: Observational

Human metapneumovirus (HMPV) is primarily recognized as a childhood pathogen, but its impact on adults remains largely underestimated. This study investigates the prevalence, clinical characteristics, and post-COVID-19 trends of HMPV infection among adults in Istanbul, Turkey.

NCT ID: NCT06296784 Completed - Bipolar Disorder Clinical Trials

An E-health Psychoeducation for People With Bipolar Disorders

Start date: May 26, 2021
Phase: N/A
Study type: Interventional

This study aims to present data on the improvement of Quality of life (QoL), biological rhythms, anxiety, depressive symptoms and the correlations between QoL and biorhythms following an e-health psychoeducational intervention for Bipolar Disoirder (BD) during Covid-19 pandemic